Safety and Tolerability of Z-100 in Patients With Early HIV Infection
NCT00016692
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Z-100
Sponsor
Zeria Pharmaceutical